Ac. Schrier et al., Point prevalence of schizophrenia in immigrant groups in Rotterdam: data from outpatient facilities, EUR PSYCHIA, 16(3), 2001, pp. 162-166
Objective. Reports of an increased incidence of schizophrenia in some immig
rant groups to The Netherlands are based exclusively on hospital data. The
aims of our study were: 1) to determine the treated point prevalence of sch
izophrenia at outpatient mental health services in Rotterdam and to compare
the results for immigrants to those for natives; and 2) to compare groups
born in The Netherlands and immigrant groups in terms of the proportions of
patients with a previous hospital admission. Method. We included all patie
nts aged between 20 and 64 who were treated for a non-affective psychosis a
t any of the outpatient mental health services in Rotterdam on October 1, 1
994. The mental health professionals responsible reported on the socio-demo
graphic and clinical characteristics of each patient. Results. Seven hundre
d and thirteen patients with a diagnosis of schizophrenia (DSM-III-R) were
identified (rate: 2.1 per 1000), The (treated) prevalence of schizophrenia
in male immigrants from Surinam and Morocco and in female immigrants from S
urinam, the Netherlands Antilles and Cape Verde was significantly higher th
an that in their native-born counterparts (odds ratios between 2 and 3). Th
e (treated) prevalence was not significantly higher in immigrants from Turk
ey, female immigrants from Morocco or male immigrants from the Antilles. Pr
oportions of patients with a previous hospital admission were similar in ea
ch ethnic group (81-93%). Conclusion. These findings are generally in line
with earlier studies, based on the Dutch psychiatric registry, which has re
ported an increase in the (treated) incidence of schizophrenia in immigrant
s from Surinam and the Netherlands Antilles and in male immigrants from Mor
occo, and no increase in the (treated) incidence in immigrants from Turkey
or female immigrants from Morocco. (C) 2001 Editions scientifiques et medic
ates Elsevier SAS.